Video Recap Now Posted: 7/28 CEO BioBreakfast With Drs Larry Gold and Bill Freytag, plus Mr. Patrick Mahaffy

Drs. Bill Freytag and Larry Gold, plus Mr. Patrick Mahaffy (L-R) explained what propelled them to grow successful bioscience companies and become leaders of the industry at the CBSA's July BioBreakfast event. Starting any business requires determination, self-discipline, persistence, a high tolerance for risk and a willingness to work very long hours. Starting a bioscience company with the goal of gaining FDA approval for a new drug or medical device requires incredible perseverance and an awful lot of money.

Thank you to the Colorado Science + Technology Park at Fitzsimons, Pfizer, Johnson and Johnson and OSI Pharmaceuticals for sponsoring! Video recaps are now available at the CBSA YouTube page: http://www.youtube.com/COBioscience

Dr. Bill Freytag serves as a member of the board of directors for four health care companies: ARCA biopharma, Inc.; GlobeImmune, Inc.; ProFoldRx, Inc., and BiOptix Inc. Dr. Freytag was Chairman and Chief Executive Officer of Aspreva Pharmaceuticals until its merger with Galenica AG. Prior to Aspreva, Dr. Freytag was President, Chief Executive Officer and Chairman of the Board of Directors of Myogen, Inc. until it was acquired by Gilead.



"It's All About Good Science" http://www.youtube.com/watch?v=z93Hs9vjRFA

"Triaging A New Idea" http://www.youtube.com/watch?v=shPyVed8jU0

"On Mistakes" http://www.youtube.com/watch?v=4d-SBbrEA78

"On Regrets" http://www.youtube.com/watch?v=SgPXB2WC8og

"Best Piece Of Advice" http://www.youtube.com/watch?v=scY7MLQFmdo

Dr. Larry Gold is the founder, Chairman of the Board and Chief Executive Officer of SomaLogic. Prior to SomaLogic, he founded NeXagen, Inc., which later became NeXstar Pharmaceuticals, Inc.



"Focusing On Early Detection" http://www.youtube.com/watch?v=ppI4HkG2dwU

"On Genomics" http://www.youtube.com/watch?v=6nHUdZjumIU

"Don't Fall In Love With Your Idea" http://www.youtube.com/watch?v=9gAttLxvDf4

"On Best Advice From A Venture Capitalist" http://www.youtube.com/watch?v=D7bbwMvflwM

"On Teamwork" http://www.youtube.com/watch?v=qa-SQXu4mio

Mr. Patrick Mahaffy co-founded Clovis Oncology and is its President and Chief Executive Officer. Previously, he served in the same role at Pharmion Corporation, which he founded in 2000. Prior to that, Mr. Mahaffy wasPresident and Chief Executive Officer of NeXagen, Inc. and its successor, NeXstar Pharmaceuticals, Inc. Today he is also a member of the boards of directors of Orexigen Therapeutics, Inc. and Flexion Therapeutics, Inc.



"This Is Not An Industry For Shortcuts" http://www.youtube.com/watch?v=FTx2B5dLiUs

"Shortcut Horror Story" http://www.youtube.com/watch?v=Xxm_y1U1O5U

"It's A Game of Incremental Steps" http://www.youtube.com/watch?v=VgrL3kf2tns

"More On Idea Triage" http://www.youtube.com/watch?v=0kv8ptIDIxo

"My Biggest Struggle" http://www.youtube.com/watch?v=3wqX4tSG-7Y

"What Keeps Me Motivated" http://www.youtube.com/watch?v=W0Zq56ppsOI

"I Don't Live In A Regret World" http://www.youtube.com/watch?v=uWW1uzxSJYw

"On Current Funding Situation" http://www.youtube.com/watch?v=-TQqAsiiQOE

This week: CBSA's popular BioBreakfast series features three CEO entrepreneurs

Each year the CBSA dedicates one BioBreakfast to spotlighting an article within the annual Bioscience Colorado Magazine. This year's program is one you can't afford to miss. Listen as Dr. Larry Gold, Dr. Bill Freytag and Patrick Mahaffy explain what propelled them to grow successful bioscience companies and become leaders of the industry.

Starting any business requires determination, self-discipline, persistence, a high tolerance for risk and a willingness to work very long hours. Starting a bioscience company with the goal of gaining FDA approval for a new drug or medical device requires incredible perseverance and an awful lot of money. Behind every Colorado bioscience company are men and women who have embraced these challenges and took them on with a zeal that not everyone possesses.

Wednesday, Jul 28, 2010 7:30 AM - 9:30 AM
Anschutz Medical Campus - Research Complex 2 - 12700 East 19th Avenue - TriVisible Room, Second Floor, P15-2100 - Aurora, CO 80045

CBSA members are free: non-yet members are $50 per registrant.

Thank you to the Colorado Science + Technology Park at Fitzsimons, Pfizer, Johnson and Johnson and OSI Pharmaceuticals for sponsoring this event!

Link to register

July Issue: Focus Newsletter

Inside This Issue:

Letter from the President

Theodorescu to Lead UCCC

CAN Update

Boettcher Investigaors Honored

BioBusiness Solutions

BioWest Conference

Link to the Newsletter pdf

NATUREJobs.com -- Mile-high dreams

“'Because we have only a handful of venture capitalists in Colorado, most of our companies have to go out of state to raise capital,' says Denise Brown, interim executive director of the Colorado BioScience Association. 'And that's a little hard, because investors like to be geographically close to their companies.' Denver's geographical isolation from big population centres on the nation's coastlines can be a hindrance. 'What we lack is critical mass, which is enjoyed by the tier-one sectors,' says Brown, referring to places such as San Diego and Boston.

What Denver lacks in capital, it makes up for in innovation and entrepreneurial spirit, say some resident scientists. Bioscience company creation and employment growth in the past five years exceeded the national average, according to statistics compiled by the Metro Denver Economic Development Corporation. And the public universities are doing a good job of fostering innovation. According to Brown, of the 20–25 new companies every year in Colorado, 75% are formed to develop university-based technologies. Colorado's 400 bioscience companies employ approximately 18,000 people statewide."

Link to NATUREJobs.com

CBSA Commends Boettcher Foundation on Historic Launch of Webb-Waring Biomedical Research Program & 1st Class of Boettcher Investigators

"The first class of ‘Boettcher Investigators’ in the Webb-Waring Biomedical Research Program was introduced by Edward D. “Ted” White III, Chairman of the Boettcher Foundation Board of Trustees. Colorado Governor Bill Ritter, Jr.; Gregory Downey, M.D., Executive Vice President of Academic Affairs at National Jewish Health and Professor of Medicine, Pediatrics and Immunology at University of Colorado’s School of Medicine; and Timothy W. Schultz, President and Executive Director of the Boettcher Foundation, also spoke at this historic event."

Link to Genetic Engineering & Biotechnology News

DBJ Exclusive: "‘Fund of funds’ a top priority as Baumunk takes over CBSA"

"Holli Baumunk took over as president and CEO of the Colorado BioScience Association (CBSA) on July 12. She already was familiar with the state’s biotech drug and medical device companies from working as vice president of the Metro Denver Economic Development Corp.

A top priority of her first year will be working on creating a “fund of funds,” designed to supply capital to private venture funds investing in startup companies that commercialize Colorado technologies in the biotech drug, medical device, biofuel and clean technology fields. An industry road map prepared for the CBSA in 2008 recommended pushing for a $250 million “fund of funds” similar to ones in other states that use money from state employee pension funds and other investors."

Link to Greg Avery's profile of Holli Baumunk in today's DBJ

Colorado Industry Updates

Recap of recent CBSA Industry Updates:

Colorado BioScience Association Hosts Second Annual Career and ... The Colorado BioScience Association (CBSA) is hosting its second annual Career and Resource Fair Wednesday, April 28, from 1 to 4 pm at the Jefferson County ... 4-24-2010

Colorado BioScience Association Showcases Colorado's Bioscience ... Colorado, with the Colorado BioScience Association (CBSA) in the lead role, will be heavily represented at the Biotechnology Industry Organization's BIO ... 5-3-2010

Video Recap: 2010 Boettcher Investigator Launch News Conference

Note: the Boettcher Foundation is a 2010 Gold Sponsor of the Colorado BioScience Association.

Colorado Governor Bill Ritter, Jr., at the Governor's Residence - Welcome to the Conference


Timothy W. Schultz, President and Executive Director of the Boettcher Foundation - About the Program


Edward D. "Ted" White III, Chairman of the Boettcher Foundation Board of Trustees Announces 2010 Boettcher Investigators


Gregory Downey, M.D., Executive Vice President of Academic Affairs at National Jewish Health and Professor of Medicine, Pediatrics and Immunology at University of Colorado's School of Medicine - On Behalf of Colorado's Research Institutions


Timothy W. Schultz, President and Executive Director of the Boettcher Foundation - Concluding Remarks


Link to the Boettcher Investigators' You Tube Channel